Health care is undergoing an important and well-needed shift from a one-size-fits-all approach to more personalized, precise, patient-focused care. A similar approach needs to be implemented at scale ...
Felicione is an independent clinical research scientist and principal investigator. Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising ...
If researchers hope to lean on data from a single trial for therapeutic approval, it is important to communicate with the FDA ...
The US Food and Drug Administration (FDA) on Wednesday finalized guidance for sponsors on interacting with the agency on complex innovative trial designs (CID) for drugs and biologics. The nine-page ...
The FDA agreed that the design of a Phase 3 trial testing privosegtor in optic neuritis could support a future approval ...
Creating a Proxy for Baseline Eastern Cooperative Oncology Group Performance Status in Electronic Health Records for Comparative Effectiveness Research in Advanced Non–Small Cell Lung Cancer ...
Digital patient profiles and real-world data enhance oncology trial design, patient recruitment, and reduce trial failure risks. Phesi's platform aligns trial designs with real-world data, minimizing ...
Projecting Individualized Probabilities of Developing Bladder Cancer in White Individuals Phase I clinical trials of new anticancer therapies determine suitable doses for further testing. Optimization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results